Featured Research

from universities, journals, and other organizations

Loss Of New Cell Growth Gene Linked To Certain Human Cancers

Date:
October 1, 2001
Source:
Massachusetts General Hospital
Summary:
Researchers at Massachusetts General Hospital (MGH) have found that the loss of a recently discovered gene involved in cell growth may play an important role in the progression of some human cancers. The gene, called Cables, was discovered by the MGH team last year, and the latest results are published in the October 1 issue of Cancer Research.

Researchers at Massachusetts General Hospital (MGH) have found that the loss of a recently discovered gene involved in cell growth may play an important role in the progression of some human cancers. The gene, called Cables, was discovered by the MGH team last year, and the latest results are published in the October 1 issue of Cancer Research.

"The Cables gene may be an important tumor suppressor gene located on chromosome 18," says principal investigator Lawrence Zukerberg, MD, of the MGH Department of Pathology. "People have known that a region of that chromosome is often missing in cancer cells, and they've been searching for cancer genes around that area for some time now."

Zukerberg and his colleagues found that the Cables gene is located on a chromosomal region that is frequently lost in colon, pancreatic, and squamous cancers. They also discovered that expression of the Cables protein is missing in these cancer cells. "We stained human tumor tissues such as colon and head and neck squamous cell carcinomas ? and found that 50 to 60 percent seem to be missing this protein," Zukerberg says.

The Cables protein normally acts to inhibit cell growth through a chain reaction effect. Cables prompts a protein called Wee1 to interact with another protein called cdk2, which plays a key role in encouraging cells to divide and grow. When it interacts with the Wee1 protein, however, cdk2's activity is diminished. So ultimately, expression of the Cables protein leads to decreased cell division.

Zukerberg's recent findings indicate that expression of the Cables protein may be important for thwarting the uncontrolled cell growth that is indicative of cancer. Without the protein, cells may be able to divide faster and could eventually become cancerous if they have a growth advantage over neighboring cells.

The next step for the MGH researchers is to try to prove that the Cables gene is a true tumor suppressor. They plan to knock out the gene in a mouse model to see if the effect leads to tumor development. They will also sequence the Cables gene from primary human tumor tissues to look for any potential mutations.

Other scientists involved in the study include Chin-Lee Wu, MD, PhD, Hua Xiao, MD, PhD, Daniel Chung, MD, Yenning Chuang, and Sandra Kirley. Laboratory support was provided by Scott McDougal, MD, Chief of Urology at MGH.

The Massachusetts General Hospital, established in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $300 million and major research centers in AIDS, the neurosciences, cardiovascular research, cancer, cutaneous biology, photomedicine, transplantation biology. In 1994, the MGH joined with Brigham and Women's Hospital to form Partners HealthCare System, an integrated health care delivery system comprising the two academic medical centers, specialty and community hospitals, a network of physician groups and non acute and home health services.


Story Source:

The above story is based on materials provided by Massachusetts General Hospital. Note: Materials may be edited for content and length.


Cite This Page:

Massachusetts General Hospital. "Loss Of New Cell Growth Gene Linked To Certain Human Cancers." ScienceDaily. ScienceDaily, 1 October 2001. <www.sciencedaily.com/releases/2001/10/011001072058.htm>.
Massachusetts General Hospital. (2001, October 1). Loss Of New Cell Growth Gene Linked To Certain Human Cancers. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2001/10/011001072058.htm
Massachusetts General Hospital. "Loss Of New Cell Growth Gene Linked To Certain Human Cancers." ScienceDaily. www.sciencedaily.com/releases/2001/10/011001072058.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins